63059-56-3

Usage

Uses

Used in Dye and Pigment Production:
4,5-dichloro-N-ethyl-2-nitroaniline is utilized as an intermediate in the synthesis of various dyes and pigments. Its unique chemical structure allows it to contribute to the color and stability of these products, making it a valuable component in the manufacturing process of the dye and pigment industry.

InChI:InChI=1/C8H8Cl2N2O2/c1-2-11-7-3-5(9)6(10)4-8(7)12(13)14/h3-4,11H,2H2,1H3

Upstream product

• 89-69-0 2,4,5-Trichloronitrobenzene 
• 75-04-7 ethylamine 
• 6306-39-4 1,2-dichloro-4,5-dinitrobenzene 
• 2339-78-8 1,2-dichloro-4-fluoro-5-nitrobenzene 
• 95-50-1 1,2-dichloro-benzene 

Downstream Products

• 63134-16-7 4.5-Dichlor-N-aethyl-phenylendiamin-(1.2) 

Relevant academic research and scientific papers

NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS

The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS

The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

NOVEL TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS

The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

NOVEL TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS

The present invention relates to compounds of general formula (I), and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

Control of the J-Aggregation Phenomenon by Variation of the N-Alkyl-Substituents

Cyanine dyes (1a-d) with the 5,5',6,6'-tetrachloro-1,1'-dialkyl-3,3'-di-(3-carboxypropyl)-benzimidocarbocyanine chromophore differing only in the chain length of their alkyl groups in 1,1'position have been synthesized spectroscopically characterized, and compared with 5,5',6,6'-tetrachloro-1,1'-diethyl-3,3'-di-(4-sulfobutyl)-benzimidocarbocyanine (TDBC).In aqueous solution the dyes form J-aggregates which, depending on the alkyl group chain length, exhibit J-bands differing in spectral position, bandwidth, and in the number of peaks.